![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual |
| Malignant Lymphoma |
|
Free Subscription
2 Am J Surg Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Malignant Lymphoma is free of charge.
Pediatric-Type Follicular Lymphoma of the Conjunctiva: Shared Histologic and
Molecular Features With the Nodal Counterpart.
Am J Surg Pathol. 2025 Nov 13. doi: 10.1097/PAS.0000000000002484.
PubMed
Abstract available
The Utility of TRBC1 Immunohistochemistry in the Evaluation of T-Cell Lymphomas.
Am J Surg Pathol. 2025;49:1258-1265.
PubMed
Abstract available
Mantle cell lymphoma with KMT2A rearrangement.
Blood. 2025;146:2491.
PubMed
Time from symptom recognition to cancer diagnosis and factors linked to delayed
diagnosis of hematological childhood cancers at a tertiary hospital in uganda: a
mixed methods study.
BMC Cancer. 2025;25:1756.
PubMed
Abstract available
Harnessing Arginase-2-specific CD8+ T cells to target immunosuppressive Cutaneous
T cell Lymphoma.
Br J Dermatol. 2025 Nov 10:ljaf450. doi: 10.1093.
PubMed
Abstract available
T-Cell-Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma:
Current Evidence, Sequencing, and Future Directions.
Eur J Haematol. 2025 Nov 9. doi: 10.1111/ejh.70063.
PubMed
Abstract available
Old methods, lasting impact in relapsed/refractory primary mediastinal B-cell
lymphoma.
Haematologica. 2025 Nov 13. doi: 10.3324/haematol.2025.289153.
PubMed
Abstract available
Antibody-Drug Conjugates and Bispecific Antibodies for Lymphoma: Partners of
Convenience or a Perfect Match.
J Clin Oncol. 2025 Nov 7:JCO2502200. doi: 10.1200/JCO-25-02200.
PubMed
Homocysteine-driven oxidative stress in pediatric lymphoma: a cross-sectional
study of metabolic and genetic modulators.
Leuk Lymphoma. 2025 Nov 11:1-10. doi: 10.1080/10428194.2025.2586081.
PubMed
Abstract available
The IL-1R and NFKBIZ pathway mediates immunoregulatory responses and
immunotherapy efficacy in anaplastic large cell lymphoma.
Leukemia. 2025 Nov 12. doi: 10.1038/s41375-025-02809.
PubMed
Abstract available
Correction: Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets
for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma.
Leukemia. 2025 Nov 10. doi: 10.1038/s41375-025-02811.
PubMed
Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept.
Leukemia. 2025 Nov 7. doi: 10.1038/s41375-025-02794.
PubMed
Abstract available
The integration of gene mutations and copy number variations refines the
prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana
Linfomi MCL0208 clinical trial.
Leukemia. 2025 Nov 7. doi: 10.1038/s41375-025-02795.
PubMed
Thank you for your interest in scientific medicine.